Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Ku E, Lipkowitz MS, Appel LJ, Parsa A, Gassman J, Glidden DV, Smogorzewski M, Hsu CY.

Kidney Int. 2017 Feb;91(2):443-450. doi: 10.1016/j.kint.2016.09.033. Epub 2016 Dec 4.

2.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

3.

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).

Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.

4.

Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.

Bodonyi-Kovacs G, Ma JZ, Chang J, Lipkowitz MS, Kopp JB, Winkler CA, Le TH.

J Am Soc Nephrol. 2016 Oct;27(10):3140-3152. Epub 2016 Mar 3.

5.

APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD.

Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1771-1777. doi: 10.2215/CJN.01180117. Epub 2017 Oct 19.

6.

Race, APOL1 Risk, and eGFR Decline in the General Population.

Grams ME, Rebholz CM, Chen Y, Rawlings AM, Estrella MM, Selvin E, Appel LJ, Tin A, Coresh J.

J Am Soc Nephrol. 2016 Sep;27(9):2842-50. doi: 10.1681/ASN.2015070763. Epub 2016 Mar 10.

7.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

8.

APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.

Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM.

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

9.

Plasma apolipoprotein L1 levels do not correlate with CKD.

Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC.

J Am Soc Nephrol. 2014 Mar;25(3):634-44. doi: 10.1681/ASN.2013070700. Epub 2013 Nov 14.

10.

Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.

Tin A, Grams ME, Estrella M, Lipkowitz M, Greene TH, Kao WH, Li L, Appel LJ.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1353-9. doi: 10.2215/CJN.12221115. Epub 2016 May 26.

11.

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI; Systolic Blood Pressure Intervention Trial (SPRINT).

Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.

12.

APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.

Chen TK, Estrella MM, Vittinghoff E, Lin F, Gutierrez OM, Kramer H, Lewis CE, Kopp JB, Allen NB, Winkler CA, Bibbins-Domingo KB, Peralta CA.

Kidney Int. 2017 Oct;92(4):964-971. doi: 10.1016/j.kint.2017.03.028. Epub 2017 May 23.

13.

APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.

Mukamal KJ, Tremaglio J, Friedman DJ, Ix JH, Kuller LH, Tracy RP, Pollak MR.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.

14.

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; SK Investigators.

Kidney Int. 2013 Jan;83(1):114-20. doi: 10.1038/ki.2012.263. Epub 2012 Jul 25.

15.

APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.

Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI.

Kidney Int. 2016 Aug;90(2):389-395. doi: 10.1016/j.kint.2016.02.032. Epub 2016 May 6.

16.

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.

Matsha TE, Kengne AP, Masconi KL, Yako YY, Erasmus RT.

BMC Genet. 2015 Jun 26;16:69. doi: 10.1186/s12863-015-0228-6.

17.

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

Riella LV, Sheridan AM.

Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3.

PMID:
26049628
18.

Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.

Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY.

Kidney Int. 2015 May;87(5):1055-60. doi: 10.1038/ki.2014.376. Epub 2014 Dec 10.

19.

APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study.

Stanifer JW, Karia F, Maro V, Kilonzo K, Qin X, Patel UD, Hauser ER.

PLoS One. 2017 Jul 21;12(7):e0181811. doi: 10.1371/journal.pone.0181811. eCollection 2017.

20.

Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry.

Horowitz CR, Abul-Husn NS, Ellis S, Ramos MA, Negron R, Suprun M, Zinberg RE, Sabin T, Hauser D, Calman N, Bagiella E, Bottinger EP.

Contemp Clin Trials. 2016 Mar;47:101-8. doi: 10.1016/j.cct.2015.12.020. Epub 2015 Dec 30.

Supplemental Content

Support Center